Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and terbutaline

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with terbutaline in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(terbutaline)		Trials
(terbutaline)		Recent Studies (post-2010) (terbutaline)
9,1561875523,216844322

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buehn, MJ; Dabney, JM; Dobbins, DE1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and terbutaline

ArticleYear
The inflammatory actions of platelet activating factor are blocked by levorotatory terbutaline.
    Microcirculation, endothelium, and lymphatics, 1990, Volume: 6, Issue:6

    Topics: Animals; Blood Pressure; Bradykinin; Dogs; Edema; Histamine; Inflammation; Injections, Intra-Arterial; Lymph; Lymphatic System; Molecular Conformation; Platelet Activating Factor; Receptors, Adrenergic, beta; Terbutaline

1990